{"result": "(\"entity\"<|>BETHESDA SYSTEM<|>ORGANIZATION<|>The Bethesda System is a classification system for reporting thyroid cytopathology, providing diagnostic terminology and morphologic criteria for thyroid lesions.)\n##\n(\"entity\"<|>AMERICAN THYROID ASSOCIATION<|>ORGANIZATION<|>The American Thyroid Association is a professional organization that provides guidelines for the management of thyroid nodules and differentiated thyroid cancer.)\n##\n(\"entity\"<|>BONGIOVANNI ET AL.<|>PERSON<|>Bongiovanni et al. refers to a group of researchers who conducted a meta-analysis on the Bethesda System for Reporting Thyroid Cytopathology.)\n##\n(\"entity\"<|>CIBAS ET AL.<|>PERSON<|>Cibas et al. refers to researchers who contributed to the Bethesda System for Reporting Thyroid Cytopathology.)\n##\n(\"entity\"<|>NATIONAL CANCER INSTITUTE<|>ORGANIZATION<|>The National Cancer Institute is a part of the U.S. National Institutes of Health and is involved in cancer research and providing information on cancer treatment and prevention.)\n##\n(\"entity\"<|>THYROID NODULES<|>EVENT<|>Thyroid nodules are abnormal growths in the thyroid gland that can be benign or malignant, and their diagnosis and management are guided by the Bethesda System.)\n##\n(\"relationship\"<|>BETHESDA SYSTEM<|>AMERICAN THYROID ASSOCIATION<|>The American Thyroid Association provides guidelines that are based on the Bethesda System for reporting thyroid cytopathology.<|>8)\n##\n(\"relationship\"<|>BETHESDA SYSTEM<|>BONGIOVANNI ET AL.<|>Bongiovanni et al. conducted a meta-analysis that evaluated the effectiveness of the Bethesda System for reporting thyroid cytopathology.<|>7)\n##\n(\"relationship\"<|>BETHESDA SYSTEM<|>CIBAS ET AL.<|>Cibas et al. contributed to the development of the Bethesda System for Reporting Thyroid Cytopathology.<|>7)\n##\n(\"relationship\"<|>BETHESDA SYSTEM<|>NATIONAL CANCER INSTITUTE<|>The Bethesda System was developed during a conference organized by the National Cancer Institute focused on thyroid fine-needle aspiration.<|>6)\n##\n(\"relationship\"<|>THYROID NODULES<|>BETHESDA SYSTEM<|>The Bethesda System is used to classify and report on thyroid nodules, guiding their diagnosis and management.<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ódulo.             Después, de acuerdo             con las     preferencias del         paciente, se\n                                                                                                 Repetir PAAF. Observación/cirugía                   puede optar por la vigilancia              o extirpación quirúrgica (opción B falsa).\n            III    Atipia de significado incierto o lesión                     5-15              en función de factores de riesgo y                  La   posibilidad      de   malignidad        en la    categoría      IV  de   la  clasificación       Bethesda       oscila     entre\n                   folicular de significado incierto                                             criterios clínicos                                  el  15% y el 30%.        Concretamente,           en el metaanálisis          de Bongiovanni et            al., la incidencia de\n            IV     Neoplasia folicular o sospechoso de                        15-30              Cirugía                                             malignidad en 1.791 casos de nódulos con citología sospechosa de neoplásica folicular era\n                   neoplasia folicular                                                                                                               de 26,1%,      muy lejos      del 50-75% que figura en la               opción C.\n            V      Sospechoso de malignidad                                   60-75              Cirugía                                             Referencias:\n            VI     Maligno                                                    97-99              Cirugía                                             • Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology:\n         PAAF: punción aspiración con aguja fina.                                                                                                      a meta-analysis. Acta Cytol. 2012;56:333-9.\n                                                                                                                                                     • Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132:658-65.\n                                                                                                                                                     • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management\n         Referencias:                                                                                                                                  Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines\n         •  Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, et al. Diagnostic terminology and morphologic criteria for cytologic        Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.\n            diagnosis of thyroid lesions: a sinopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science            • Layfield LJ, Abrams J, Cochand-Priollet B, Evans D, Gharib H, Greenspan F, et al. 2008 Post-thyroid FNA testing and treatment options:\n            Conference. Diagn Cytopathol. 2008;36:425-37.                                                                                              a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol.\n         •  Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a                 2008;36:442-8.\n            meta-analysis. Acta Cytol. 2012;56:333-9.                                                                                                • Lubitz CC, Nagarkatti SS, Faquin WC, Samir AE, Hassan MC, Barbesino G, et al. Diagnostic yield of nondiagnostic thyroid nodules is not\n         •  Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132:658-65.                              altered by timing of repeat biopsy. Thyroid. 2012; 22:590-4.\n         •  Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management              • Orija IB, Pineyro M, Biscotti C, Reddy SS, Hamrahian AH. Value of repeating a nondiagnostic thyroid fine-needle aspiration biopsy.\n            Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines          Endocr Pract. 2007;13:735-42.\n            Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.                                                 • Redman R, Zalaznick H, Mazzaferri EL, Massoll NA. The impact of assessing specimen adequacy and number of needle passes for\n                                                                                                                                                       fine-needle aspiration biopsy of thyroid nodules.\n                                                                                                                                                       Thyroid. 2006;16:55-60.\n                                                                                                                                                     • Singh RS, Wang HH. Timing of repeat thyroid fine-needle aspiration in the management of thyroid nodules. Acta Cytol. 2011;55:544.8.\n     31  Sobre      los diagnósticos citológicos siguiendo la clasificación Bethesda para\n         nódulos       tiroideos, señale la afirmación correcta:\n                                                                                                                                                 32  Según      las guías en        vigor, la punción           aspirativa con aguja fina (PAAF) en                       nódulos\n         A.   La categoría Bethesda I (no diagnóstica) imp\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}